Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Continues "Tayloring" Senior Leadership

This article was originally published in The Pink Sheet Daily

Executive Summary

BIO executive VP John Taylor returns to the agency as special counselor while FDA also fills another key liaison slot.
Advertisement

Related Content

FDA Counselor Taylor Is Acting Deputy As Hamburg Mulls Reorganization
FDA Counselor Taylor Is Acting Deputy As Hamburg Mulls Reorganization
Strange Bedfellows: Regulators May Revive Biotech Deals And IPOs
Strange Bedfellows: Regulators May Revive Biotech Deals And IPOs
Waxman Staffer Ann Witt Rejoining FDA
Waxman Staffer Ann Witt Rejoining FDA
FDA Reorganization Elevates Scientific And Food Safety Priorities
FDA Innovation And Integrity Will Be Goodman's Role Under Reorganization
Return to FDA: Senate Staffer Dorsey Becomes Senior Counselor To Sharfstein

Topics

Advertisement
UsernamePublicRestriction

Register

PS068704

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel